Sort
85,873 grants matching “alzheimers”
Alzheimer's Disease Pathology in a Primate Model
$746,202William D Hopkins · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · AG
Alzheimer's Disease Pathology in a Primate Model
$746,202William D Hopkins · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · AG
Molecular Tool Development to Identify, Isolate, and Interrogate the Rod Microglia Phenotype in Neurological Disease and Injury
$746,161Jonathan Lifshitz · Arizona Veterans Research And Education Foundation · R01 · FY2023 · AG
Palliative care needs and outcomes for dementia patients
$746,160Vyjeyanthi S Periyakoil · Stanford University · R01 · FY2021 · AG
Brain glycosphingolipids and Alzheimer's disease
$746,155Jinying Zhao · University Of Florida · R01 · FY2024 · AG
Develop an ANS-based Personalized Cognitive Training for Mild Cognitive Impairment
$746,142Feng Vankee Lin · Stanford University · R33 · FY2025 · AG
Laser Speckle Imaging Chip for Telehealth Applications
$746,130Abhishek Rege · Vasoptic Medical, Inc. · R44 · FY2018 · AG
Target Engagement Biomarkers for Alzheimer's Therapeutics
$746,126Susan M Catalano · Cognition Therapeutics, Inc. · R44 · FY2018 · AG
Effects of attention and goal-state lapses on memory in healthy and pathological aging
$746,090Anthony D Wagner · Stanford University · R01 · FY2023 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$746,084Kurt R. Brunden · University Of Pennsylvania · U01 · FY2022 · AG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$746,016Elizabeth Head · University Of Kentucky · R01 · FY2018 · AG
Mediators and Moderators of Auditory Training
$745,979Aaron R Seitz · Northeastern University · R01 · FY2023 · AG
Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease
$745,976Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2018 · AG
Identification and Characterization of Novel AD Genes
$745,967Massachusetts General Hospital · R37 · FY2004 · MH
THE SENDEP STUDY: LINKING MOLECULAR SENESCENCE CHANGES TO DEPRESSION AND COGNITIVE IMPAIRMENT IN LATE LIFE
$745,964Breno Satler Diniz · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · MH
Contributions of sleep to preclinical and clinical Alzheimer's disease
$745,956Jayandra Jung Himali · University Of Texas Hlth Science Center · R01 · FY2021 · AG
Systems Biology of Humanized models of AD and genetic suppression in Drosophila
$745,880Robert A. Reenan · Brown University · R56 · FY2017 · AG
Active Help, Immune Function and Health Outcomes in Alzheimer's Caregivers
$745,873Stephanie L Brown · State University New York Stony Brook · R01 · FY2020 · AG
Novel Volumetric Optical Microscopy to Unravel Cerebral Microvascular Architecture and the Role in Functional Neuroimaging in Human Alzheimer's Disease
$745,862Hui Wang · Massachusetts General Hospital · R01 · FY2023 · NS
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
$745,855Jinying Zhao · University Of Florida · R01 · FY2020 · AG
Age-associated cognitive changes in community dwelling adults
$745,852Alan B Zonderman · National Institute On Aging · ZIA · FY2014 · AG
Cell-specific roles for PERK in HIV-induced neuroinflammation
$745,822Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2025 · MH
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2019 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2020 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2018 · AG